On the upside
Conexant Systems (Nasdaq: CNXT) sold its Broadband Access product lines for $54 million to Ikanos Communications (Nasdaq: IKAN).
Shares of Osiris Therapeutics (Nasdaq: OSIR) rose ahead of the release of study results from a Phase III acute graft versus host disease drug trial.
Citigroup analyst Glen Yeung upgraded Advanced Micro Devices (Nasdaq: AMD) saying that the company has a favorable risk/reward profile.
On the downside
Private equity firm Ripplewood Holdings sold 26.6 million shares of RSC Holdings (NYSE: RRR).
Cell Therapeutics (Nasdaq: CTIC) submitted an application to the Food and Drug Administration for its cancer treatment pixantrone but the stock price fell.
Shares of Fifth Third Bancorp (NYSE: FITB) fell after analyst Richard Bove said investors should avoid regional banks.
In the broad market, advancing issues outpaced decliners by a margin of 10 to 9 on the NYSE and by more than 10 to 9 on Nasdaq. The Russell 2000 which tracks small cap stocks slipped a point to 580.
